Giant Biogene IPO: A Collagen Queen, or Saggy-Skinned Stepsister?
The fast-growing skin-care products maker has filed for a Hong Kong listing that could value it at about $8.5 billion Key Takeaways: Giant Biogene has filed for a Hong Kong…
RELATED ARTICLES
-
FAST NEWS: Giant Biogene initiates dividends as profit jumps
2367.HK
-
Rebounding Perfect Medical finds beauty safe haven in Hong Kong
1830.HK
- Malo Medical pitches IPO to help fill China’s dentistry gap
-
Chaoju Eye Care sees strong growth in acquisitions
2219.HK
- Medical imaging group Rimag sets growth focus with IPO
-
IFlytek hives off health unit to fund AI medical drive
002230.SHE
Discover hidden China stock gems in our weekly newsletter